SAN DIEGO, Aug. 28, 2018 /PRNewswire/ -- Tocagen Inc.
(Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy
company, today announced that Marty
Duvall, chief executive officer, will participate in a panel
discussion titled, "Chinese Capital Meets Western Innovation" on
Tuesday, September 4, at 11:20 a.m. Eastern Standard Time, at the B. Riley
FBR Annual Healthcare Conference. In addition, Mr. Duvall will
present a corporate overview at the 20th Annual Global
Investment Conference sponsored by H.C. Wainwright & Co. on
Wednesday, September 5, at
9:35 a.m. Eastern Standard Time, also
in New York City.
The live audio webcast from the H.C. Wainwright conference and
subsequent replay may be accessed by visiting the "Events
& Presentations" page in the investors section of
Tocagen's website. The webcast will be available shortly after
conclusion of the presentation and archived on the company's
website for 30 days following the presentation.
About Tocagen Inc.
Tocagen is a clinical-stage, cancer-selective gene therapy
company developing first-in-class, broadly applicable product
candidates designed to activate a patient's immune system against
their own cancer. Tocagen's lead investigational product
candidate, Toca 511 & Toca FC, is under evaluation in a pivotal
Phase 3 trial for recurrent high grade glioma (HGG), a disease with
significant unmet medical need. The U.S. Food and Drug
Administration (FDA) has granted Toca 511 & Toca FC
Breakthrough Therapy Designation for the treatment of recurrent HGG
and the European Medicines Agency (EMA) has granted Toca
511 PRIME (PRIority MEdicines) designation for the treatment of
glioma. For more information about Tocagen,
visit www.tocagen.com.
Media Contact:
Pam
Lord
Canale Communications
(619) 849-6003
pam@canalecomm.com
Investor Contact:
Elizabeth
Broder
Endurance Advisors
ebroder@enduranceadvisors.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/tocagen-to-participate-in-two-investor-conferences-next-week-300703629.html
SOURCE Tocagen Inc.